Bentham Science Logo

Track Your Manuscript:

Current Pharmaceutical Biotechnology

Volume 23, 15 Issues, 2022
ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)
This journal supports open access


Current Pharmaceutical Biotechnology , Volume 13 - Number 9

Pro-Oncogenic Cell Signaling Machinery as a Target for Oncolytic Viruses

, 13(9): 1742 - 1749

Emma Borrego-Diaz, Rajesh Mathew, Dana Hawkinson, Tuba Esfandyari, Zhengian Liu, Patrick W Lee and Faris Farassati

DOI: 10.2174/138920112800958788

Oncolytic Viruses for Induction of Anti-Tumor Immunity

, 13(9): 1750 - 1760

Alex W. Tong, Neil Senzer, Vincenzo Cerullo, Nancy Smyth Templeton, Akseli Hemminki and John Nemunaitis

DOI: 10.2174/138920112800958913

The Molecular Basis of Herpesviruses as Oncolytic Agents

, 13(9): 1795 - 1803

Laura Menotti, Gabriella Campadelli-Fiume, Patrizia Nanni, Pier Luigi Lollini and Carla De Giovanni

DOI: 10.2174/138920112800958931

Recent Clinical Experience with Oncolytic Viruses

, 13(9): 1834 - 1841

O. G. Donnelly, F. Errington-Mais, R. Prestwich, K. Harrington, H. Pandha, R. Vile and A. A. Melcher

DOI: 10.2174/138920112800958904


Nikolaos Labrou
School of Food, Biotechnology and Development
Department of Biotechnology
Agricultural University of Athens
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Pharmaceutical Biotechnology was launched in 2000. Dr. Nikolaos Labrou serves as the Editor-in-Chief of the journal.



Related Journals

Related eBooks

eBooks Catalog